Rheumnow Podcast
ACR24 Daily Recap Day2
Nov 18, 2024
Rinaldi Day, a clinical fellow from London, and Eric Dian, a rheumatologist from Summit, New Jersey, dive into the cutting-edge insights from the ACR Annual Meeting. They discuss a pivotal study linking steroid use to cardiovascular events in rheumatoid arthritis and share findings on optimizing treatment for giant cell arteritis. The conversation touches on racial biases in lung function calculations and the disparities in medication outcomes for connective tissue diseases, highlighting the urgent need for improved management strategies and monitoring.
40:15
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Cumulative steroid use in rheumatoid arthritis patients is associated with a higher risk of major adverse cardiovascular events, necessitating steroid-sparing strategies.
- Effective management of rheumatoid arthritis significantly shortens the time to conception for women, emphasizing the role of targeted therapy and preconception counseling.
Deep dives
Impact of Steroid Use on Cardiovascular Risk
Cumulative steroid use is linked to an increased risk of major adverse cardiovascular events (MACE), particularly in rheumatoid arthritis (RA) patients, as highlighted in a large Veteran Affairs cohort study. Of the nearly 19,000 patients studied, approximately 700 who experienced incident MACE had significant steroid exposure. This study underscores the necessity for clinicians to reduce steroid dependency in RA management and transition patients to steroid-sparing agents more effectively. The implications of this research emphasize the importance of addressing cardiovascular comorbidities in RA patients as part of holistic treatment plans.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
